⚠️ AI & drug safety: FDA explores OpenAI’s cderGPT to accelerate reviews 🤖💊
High-level OpenAI staff have met with the FDA—and even Musk’s “Department of Government Efficiency”—to discuss a pilot called cderGPT aimed at speeding up the Center for Drug Evaluation’s review process.
🧑⚕️ Led by FDA’s first AI officer Jeremy Walsh
📈 First AI-assisted scientific review already completed
🤝 Involves HHS AI liaison Peter Bowman-Davis
📋 No formal contract yet—still in exploratory talks
⚠️ Risks include overreliance on AI, hallucinations in key safety data
Balancing faster approvals with patient safety demands clear guardrails. How should regulators harness AI without cutting corners?
#AI #Pharma #RegTech #DrugSafety #FDA
https://www.wired.com/story/openai-fda-doge-ai-drug-evaluation/
I nearly discounted this article because of the almost dumb title, but it is a good examination of automation and use of AI in compliance.
Could #AI take the place of your bank examiner?
https://www.americanbanker.com/opinion/could-ai-take-the-place-of-your-bank-examiner
Want to create a tokenized RWAs marketplace that’s compliant with regulations? 🚀 Learn the key steps and strategies to build a secure, legal platform that fosters trust and innovation. 🔑 #Blockchain #Tokenization #CryptoCompliance #RWA #Web3 #DigitalAssets #Fintech #RegTech
https://pupuweb.com/how-can-you-build-regulation-compliant-tokenized-rwas-marketplace/
How can RegTechs improve the overall security of in-house #AI?
Fraud attacks in financial services surged 17% in 2023, with payment and account creation fraud being the top threats. Mobile channels and automated bots played a key role.
#CyberSecurity #RegTech #FinancialServices
https://fintechnews.sg/101575/regtech/fraud-attacks-financial-services-payment-account-creation-fraud/